| Members |
targetComponentId |
| Periodontitis associated with chronic familial neutropenia |
Periodontitis exacerbated by chronic familial neutropenia |
| Periodontitis associated with cyclical neutropenia |
Periodontitis exacerbated by cyclical neutropenia (disorder) |
| Periodontitis co-occurrent with Chédiak-Higashi syndrome |
Periodontitis exacerbated by Chédiak-Higashi syndrome (disorder) |
| Periodontitis co-occurrent with Cohen syndrome |
Periodontitis exacerbated by Cohen syndrome |
| Periodontitis co-occurrent with Down syndrome |
Periodontitis exacerbated by Down syndrome |
| Periodontitis co-occurrent with Ehlers-Danlos syndrome type 4 |
Periodontitis due to Ehlers-Danlos syndrome type 4 (disorder) |
| Periodontitis co-occurrent with acquired neutropenia |
Periodontitis exacerbated by acquired neutropenia |
| Periodontitis co-occurrent with cyclical neutropenia |
Periodontitis exacerbated by cyclical neutropenia (disorder) |
| Periodontitis co-occurrent with familial neutropenia |
Periodontitis exacerbated by familial neutropenia |
| Periodontitis co-occurrent with glycogen storage disease |
Periodontitis exacerbated by glycogen storage disease |
| Periodontitis co-occurrent with hypophosphatasia |
Periodontitis exacerbated by hypophosphatasia (disorder) |
| Periodontitis co-occurrent with infantile genetic agranulocytosis |
Periodontitis due to infantile genetic agranulocytosis (disorder) |
| Periodontitis co-occurrent with leukocyte adhesion deficiency |
Periodontitis due to leukocyte adhesion deficiency |
| Periostitis of other specified site, NEC |
Periostitis |
| perifert T-celle-lymfom |
Peripheral T-cell lymphoma |
| Peripheral T-cell lymphoma, pleomorphic medium and large cell |
Peripheral T-cell lymphoma |
| Peripheral T-cell lymphoma, pleomorphic small cell |
Peripheral T-cell lymphoma |
| Peripheral dysostosis |
Acrodysostosis |
| perifere entesopatier og beslægtede syndromer |
Peripheral enthesopathy |
| perifert motorisk neuron |
Lower motor neuron |
| Peripheral nerve injury NOS |
Injury of peripheral nerve (disorder) |
| traumatisk læsion af perifer nerve, ikke nærmere specificeret |
Injury of peripheral nerve (disorder) |
| sygdom i det perifere nervesystem, ikke nærmere specificeret |
Disorder of the peripheral nervous system |
| Peripheral nervous system disorder NOS |
Disorder of the peripheral nervous system |
| perifer neurit under graviditet, barn født med postnatal komplikation |
Peripheral neuritis in pregnancy |
| Perifer neurit under graviditet med postnatal komplikation |
Peripheral neuritis in pregnancy |
| Peripheral neuropathy due to chemotherapy |
Peripheral neuropathy due to and following antineoplastic therapy (disorder) |
| Peripheral vascular disease (& [NOS]) |
This concept is primitive because within clinical practice it is used in different contexts to refer to both arteries and veins of the periphery or exclusively of peripheral arteries and sometimes to describe just occlusive disease of the peripheral arteries. More detailed unambiguous concepts are available for these more specific interpretations. |
| Peripheral vascular disease (& [NOS]) |
This concept is primitive because within clinical practice it is used in different contexts to refer to both arteries and veins of the periphery or exclusively of peripheral arteries and sometimes to describe just occlusive disease of the peripheral arteries. More detailed unambiguous concepts are available for these more specific interpretations. |
| Peripheral vascular disease NOS |
This concept is primitive because within clinical practice it is used in different contexts to refer to both arteries and veins of the periphery or exclusively of peripheral arteries and sometimes to describe just occlusive disease of the peripheral arteries. More detailed unambiguous concepts are available for these more specific interpretations. |
| Peripheral vascular disease NOS |
This concept is primitive because within clinical practice it is used in different contexts to refer to both arteries and veins of the periphery or exclusively of peripheral arteries and sometimes to describe just occlusive disease of the peripheral arteries. More detailed unambiguous concepts are available for these more specific interpretations. |
| Peripheral vasodilators and related drugs |
Vasodilator (substance) |
| peritoneale tamponeringsprocedurer |
Insertion of pack into peritoneal cavity (procedure) |
| Peritoneal-venøs shunt-patency test for Leveen-shunt |
Peritoneovenous shunt patency test |
| Peritoneovenous shunt for ascites (& [LeVeen] or [Denver]) |
Creation of peritoneal-venous shunt |
| Perivesical tissue operations NOS |
Perivesical tissue operation (procedure) |
| Operationer på perivesikalt væv, ikke nærmere specificeret |
Perivesical tissue operation (procedure) |
| etablering af permanent gastrostomi med konstruktion af gastrisk sonde |
Construction of permanent stoma of stomach with insertion of gastrostomy tube (procedure) |
| Permethrinfarve |
Permethrin (substance) |
| pernasal podning |
Swab of internal nose (specimen) |
| Persisterende anteversion af femur |
Persistent congenital anteversion of femur (disorder) |
| Persistent flow of blood into graft of aorta |
Persistent flow of blood into aneurysm sac following endovascular insertion of stent graft into aorta |
| persisterende indsivning af blod i stentgraft |
Persistent flow of blood into aneurysm sac following endovascular insertion of stent graft (disorder) |
| Person NOS counseled |
Person counselled |
| Person NOS counselled |
Person counselled |
| patients familiemedlem |
Person in the family (person) |
| Person made appointment NOS |
Person making appointment |
| Person made appointment NOS |
Person making appointment |
| anamnese vedr. personlige forhold: malignt neoplasme i hud |
History of primary malignant neoplasm of skin (situation) |
| Personal mobility assistive device |
Mobility aid (physical object) |
| Personal status NOS |
Personal status |
| Personlig status, ikke nærmere specificeret |
Personal status |
| Personality finding |
Character trait finding |
| Personnel/indust.relat. NOS |
Personnel/industrial relations |
| Personnel/industrial relations NOS (occupation) |
Personnel/industrial relations |
| kighostevaccination, ikke nærmere specificeret |
Administration of pertussis vaccine |
| Pertussis vaccination NOS |
Administration of pertussis vaccine |
| pesticidprodukt |
Pesticide |
| Pesticide product overdose |
Pesticide poisoning |
| Petekkier hos foster eller nyfødt |
Perinatal cutaneous petechiae (disorder) |
| Petit mal |
Absence seizures present with a cessation of activity and impaired awareness associated with generalised spike and wave on EEG (electroencephalogram). An absence seizure is a generalised onset seizure and therefore, it originates at some point within, and rapidly engages, bilaterally distributed networks. |
| Petroleum poisoning |
Toxic effect of petroleum product |
| Phalanx of second finger |
Structure of phalanx of index finger |
| farmaceutisk væske eller opløsning |
Pharmaceutical fluid or solution agent (substance) |
| farmaceutisk smøremiddel |
Lubricant |
| Pharmacist NOS |
Pharmacist |
| Pharmacist NOS |
Pharmacist |
| Faryngorrafi vedr. ganespalte |
Repair of cleft palate |
| Pharyngoscopy: [diagnostic NOS] or [NEC] |
Endoscopy of pharynx (procedure) |
| Pharynx excision |
Pharyngectomy |
| Pharynx operations NOS |
Operation on pharynx |
| Pharynx operations NOS |
Operation on pharynx |
| fasanadenovirus 1 |
Turkey adenovirus 3 (organism) |
| Phendimetrazine tartrate 105mg capsule |
Phendimetrazine only product in oral dose form |
| phendimetrazintartrat 105 mg kapsel med modificeret udløsning |
Phendimetrazine only product in oral dose form |
| Phendimetrazine tartrate 105mg prolonged-release oral capsule |
Phendimetrazine only product in oral dose form |
| pheniramin 0,0315 % + naphazolin 0,02675 % opløsning til oftalmisk anvendelse |
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution |
| phenobarbital 20 mg/5 ml eliksir |
Product containing precisely phenobarbital 4 milligram/1 milliliter conventional release oral solution (clinical drug) |
| overdosis af phenothiazin |
Phenothiazine and/or phenothiazine derivative overdose |
| phenoxybenzaminhydrochlorid 50 mg/ml koncentrat til infusionsvæske, ampul a 2 ml |
Product containing precisely phenoxybenzamine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| phenoxymethylpenicillin 0,3 % øjendråber |
Phenoxymethylpenicillin potassium 3 mg/mL eye solution |
| Phenylacetate--CoA ligase |
Phenylacetate--CoA ligase |
| antipsykotisk phenylbutylpiperadinderivatmiddel |
Phenylbutylpiperadine derivative |
| phenylephrin 0,125 % næsedråber, opløsning |
Product containing precisely phenylephrine hydrochloride 1.25 milligram/1 milliliter conventional release nasal solution (clinical drug) |
| phenylephrin 0,25 % opløsning, næsedråber |
Product containing precisely phenylephrine hydrochloride 2.5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
| phenylephrin 0,25 % opløsning dråber til oral anvendelse |
Phenylephrine 2.5 mg/mL oral solution |
| phenylephrin 0,5 % opløsning, næsedråber |
Product containing precisely phenylephrine hydrochloride 5 milligram/1 milliliter conventional release nasal solution (clinical drug) |
| phenylephrin 1 % opløsning, næsedråber |
Phenylephrine hydrochloride 10 mg/mL nasal solution |
| phenylephrin 5 mg + promethazin 6,25 mg + codein 10 mg i 5 ml syrup til oral anvendelse |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
| Phenylephrine hydrochloride 10% conventional release eye drops |
Phenylephrine hydrochloride 100 mg/mL eye solution |
| phenylephrinhydrochlorid 10 % øjendråber til engangsbrug |
Phenylephrine hydrochloride 100 mg/mL eye solution |
| Phenylephrine hydrochloride 2.5% conventional release eye drops |
Phenylephrine hydrochloride 25 mg/mL eye solution |
| phenylephrinhydrochlorid 2,5 % øjendråber til engangsbrug |
Phenylephrine hydrochloride 25 mg/mL eye solution |
| phenylephrinhydrochlorid 2,5 % opløsning |
Product containing only phenylephrine (medicinal product) |
| Phenylketonuria due to tetrahydrobiopterin deficiency |
Tetrahydrobiopterin synthesis defect |
| phenylpiperazinantidepressivum |
Phenylpiperazine derivative (substance) |
| bivirkning af phenylpropanolaminhydrochlorid |
Adverse reaction to phenylpropanolamine |
| allergi over for phenylpropanolaminhydrochlorid |
Allergy to phenylpropanolamine (finding) |
| phenytoinnatrium 30 mg kapsel med modificeret udløsning |
Phenytoin only product in oral dose form |
| Phenytoin sodium 30mg prolonged-release oral capsule |
Phenytoin only product in oral dose form |
| Phialophora richardsiae |
Pleurostomophora richardsiae (organism) |
FHIR